Check out our most popular compounded medications! Get Started
Estradiol 2 mg/Progesterone 100 mg Slow Release (MEM4) Oral Capsules are a hormone replacement therapy (HRT) formulation designed to alleviate symptoms of menopause, such as hot flashes, night sweats, and vaginal dryness. These capsules are also used to prevent osteoporosis in postmenopausal women by maintaining bone density. The inclusion of Methocel E4M, a controlled-release polymer, ensures a consistent and prolonged delivery of the hormones estradiol and progesterone, mimicking the body's natural release patterns. This slow-release mechanism enhances patient convenience by reducing the need for frequent dosing and promotes adherence to the therapeutic regimen.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Estradiol and progesterone are hormones that play key roles in women's health, particularly in the regulation of the menstrual cycle and maintenance of pregnancy. Estradiol is a form of estrogen, a female sex hormone produced by the ovaries, which is responsible for the development and maintenance of female reproductive tissues and secondary sexual characteristics. Progesterone, another female sex hormone produced by the ovaries, corpus luteum, and placenta, is crucial for regulating the menstrual cycle and supporting early stages of pregnancy. Together, these hormones are often used in hormone replacement therapy (HRT) to alleviate symptoms associated with menopause, such as hot flashes, vaginal dryness, and bone loss, as well as to prevent endometrial hyperplasia in women with an intact uterus.
The Estradiol 2 mg/Progesterone 100 mg Slow Release (MEM4) Oral Capsules are a specialized formulation designed to deliver these hormones in a controlled manner. By incorporating Methocel E4M, a hydrophilic methylcellulose polymer, the capsules ensure a slow and steady release of estradiol and progesterone into the bloodstream. This controlled-release mechanism mimics the body's natural hormone fluctuations more closely than immediate-release formulations, potentially reducing the risk of side effects and improving the overall balance of hormone levels within the body.
For patients, this means a more consistent relief from menopausal symptoms throughout the day without the peaks and troughs associated with immediate-release hormone therapies. The reduced dosing frequency also simplifies the medication regimen, which can lead to better adherence and overall treatment outcomes. For prescribers, the slow-release formulation offers a more predictable pharmacokinetic profile, allowing for more precise management of hormone levels and a reduced likelihood of breakthrough symptoms or adverse effects associated with fluctuating hormone concentrations.
It is important to note that hormone replacement therapy, including the use of estradiol and progesterone, is not suitable for everyone. It should be used with caution in patients with a history of hormone-sensitive cancers, thromboembolic disorders, or liver disease. As with any medication, the risks and benefits of HRT should be thoroughly discussed with patients, and the lowest effective dose should be used for the shortest duration necessary to achieve treatment goals.
If you have any questions or require further information about the Estradiol 2 mg/Progesterone 100 mg Slow Release (MEM4) Oral Capsules, or if you need guidance on whether this formulation is appropriate for your patient, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is dedicated to providing expert advice and support to ensure the best possible care for your patients.
The Estradiol 2 mg/Progesterone 100 mg Slow Release (MEM4) Oral Capsules are a hormone replacement therapy (HRT) designed to alleviate symptoms of menopause such as hot flashes, vaginal dryness, and bone loss. Estradiol is a form of estrogen, a female sex hormone produced by the ovaries, which diminishes during menopause. Progesterone is another female hormone important for the regulation of ovulation and menstruation. In women with an intact uterus, progesterone is combined with estrogen to prevent the risk of endometrial hyperplasia that can be caused by estrogen alone. The Methocel E4M polymer in these capsules ensures a slow and sustained release of the hormones, aiming to maintain stable hormone levels and minimize fluctuations that could cause side effects.
When considering the use of Estradiol/Progesterone Slow Release Capsules, it is important to be aware of potential drug interactions. Estradiol and progesterone can interact with a variety of medications, potentially altering their effects. For instance, certain enzyme inducers such as carbamazepine, phenytoin, and St. John's Wort can increase the metabolism of hormones, reducing their effectiveness. Conversely, enzyme inhibitors like ketoconazole and erythromycin may increase hormone levels, raising the risk of side effects. Patients should also be cautious when taking anticoagulants, as estrogen can increase the risk of blood clots, potentially requiring dose adjustments of anticoagulant medication.
Additionally, drugs that affect liver enzymes, specifically the cytochrome P450 enzymes, can influence the clearance of both estradiol and progesterone. Substances such as grapefruit juice may also interact with these enzymes, potentially leading to increased hormone levels and side effects. It is also important to note that smoking can decrease the effectiveness of estrogen therapy and increase the risk of cardiovascular side effects. Patients should be advised to avoid smoking while taking this medication.
Thyroid function tests may be affected by estrogen therapy, as estrogen increases thyroid-binding globulin, which could lead to elevated total thyroid hormone levels in the blood, while free thyroid hormone levels remain unchanged. Patients on thyroid hormone replacement therapy may require monitoring and potential dose adjustments. Furthermore, estrogen can affect glucose tolerance, and diabetic patients may need to monitor their blood glucose levels more closely and adjust their antidiabetic medication accordingly.
Patients should be encouraged to inform their healthcare providers of all medications, supplements, and herbal products they are taking to ensure safe and appropriate use of Estradiol/Progesterone Slow Release Capsules. If you have any questions or require further information regarding potential drug interactions with this formulation, please reach out to us at Bayview Pharmacy for assistance.
The Estradiol 2 mg/Progesterone 100 mg Slow Release (MEM4) Oral Capsules are a specialized formulation designed to provide a steady release of hormones into the bloodstream. This is achieved through the use of Methocel E4M, a hydrophilic methylcellulose derivative that forms a gel matrix when it comes into contact with gastric fluids. Methocel E4M is a high-viscosity grade of hypromellose, which is widely used in pharmaceutical applications for its controlled-release properties.
Upon ingestion, the Methocel E4M in the capsule swells and forms a gel barrier around the active ingredients, estradiol and progesterone. This gel barrier controls the rate at which the hormones are released from the capsule and absorbed by the body. The process is influenced by the viscosity of the Methocel E4M polymer and the capsule's design. The slow dissolution of the gel matrix ensures a gradual and sustained release of the hormones, mimicking the body's natural rhythm and maintaining consistent blood levels over an extended period, typically 24 hours.
Estradiol and progesterone are hormones that play vital roles in women's health, particularly in the regulation of the menstrual cycle and maintenance of the reproductive system. Estradiol, a form of estrogen, is responsible for the development and maintenance of female sex characteristics and has important functions in bone health, cardiovascular function, and skin integrity. Progesterone, on the other hand, prepares the lining of the uterus for potential pregnancy after ovulation and modulates the menstrual cycle. Together, these hormones can be used to treat various disease states, including menopausal symptoms such as hot flashes, vaginal dryness, and osteoporosis prevention. They are also used in hormone replacement therapy (HRT) for women with low hormone levels or in certain cases of infertility.
The slow-release formulation of estradiol and progesterone in these capsules ensures that the hormones are delivered in a manner that reduces the fluctuations in blood levels associated with immediate-release dosage forms. This can lead to improved efficacy and reduced incidence of side effects, which are often related to peaks and troughs in hormone levels. Additionally, the convenience of once-daily dosing enhances patient compliance, an important factor in long-term therapies such as HRT.
It is important for both patients and prescribers to understand that the use of hormone therapy should be individualized and based on a thorough evaluation of the potential benefits and risks. Regular monitoring and follow-up are essential to ensure the optimal outcome of the therapy. If you have any questions or require further information about the Estradiol 2 mg/Progesterone 100 mg Slow Release (MEM4) Oral Capsules, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide the support and guidance you need to make informed decisions about your health care.
The Estradiol 2 mg/Progesterone 100 mg Slow Release (MEM4) Oral Capsule is a hormone replacement therapy that combines two hormones, estradiol and progesterone, in a controlled-release formulation. It is designed to release these hormones over an extended period to maintain steady levels in the body, which can help manage the symptoms associated with hormone imbalances or deficiencies.
The controlled-release mechanism of MEM4 capsules works through the use of Methocel E4M, which is a type of hydrophilic polymer that swells and forms a gel when it comes into contact with fluids. This gel matrix controls the release rate of the active ingredients, allowing the medication to be absorbed slowly and continuously over time, thereby extending the duration of its effects.
The benefits of using MEM4 slow release capsules include more consistent hormone levels in the body, reduced dosing frequency (which improves patient compliance), and potentially fewer side effects as hormone levels remain stable, avoiding the peaks and troughs often associated with immediate-release formulations.
The dosing schedule for MEM4 capsules will be determined by your healthcare provider, based on your individual needs and treatment plan. Due to their slow-release formulation, these capsules may be taken less frequently than immediate-release hormone medications. Always follow your healthcare provider's instructions regarding dosage.
As with any medication, MEM4 capsules can potentially cause side effects. Common side effects may include gastrointestinal discomfort, breast tenderness, headache, and mood swings. Notify your healthcare provider if you experience any severe or persisting side effects.
While MEM4 capsules can be taken with other medications, it is essential to inform your healthcare provider of all medications, supplements, and herbal products you are taking to avoid any potential interactions. Some substances may affect the efficacy of hormone replacement therapy or alter the controlled-release characteristics of MEM4 capsules.
MEM4 capsules are not recommended for use during pregnancy. If you are pregnant or planning to become pregnant, discuss alternative treatment options with your healthcare provider. Hormone replacement therapy is usually contraindicated during pregnancy.
Store MEM4 capsules in a cool, dry place away from direct light and moisture. Keep the medication out of reach of children and pets. Do not store in the bathroom or near a sink and be sure to keep the capsules in their original container until it is time to take them.
If you miss a dose of MEM4 capsules, take it as soon as you remember. However, if it is nearly time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not take a double dose to make up for a missed one. Contact your healthcare provider if you have missed several doses or are unsure of how to proceed.
Yes, MEM4 capsules are specifically designed to help manage symptoms associated with menopause, such as hot flashes, mood swings, sleep disturbances, and vaginal dryness. By providing controlled-release hormone therapy, they can help stabilize hormone levels and alleviate menopausal discomfort.
People with a history of hormone-sensitive cancers, liver disease, uncontrolled hypertension, thromboembolic disorders, or undiagnosed vaginal bleeding should not take MEM4 capsules. Additionally, those who are allergic to estradiol, progesterone, or any of the ingredients in these capsules should avoid their use. Always consult with your healthcare provider to determine if MEM4 is appropriate for your condition.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
